Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study-Reference-Cited by-同舟云学术

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study

Published:2022-05 Issue: Volume:39 Page:14-21
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Grossmann Nico C.,Rajwa Pawel,Quhal Fahad,König Frederik,Mostafaei Hadi,Laukhtina Ekaterina,Mori Keiichiro,Katayama Satoshi,Motlagh Reza Sari,Fankhauser Christian D.,Mattei Agostino,Moschini Marco,Chlosta Piotr,van Rhijn Bas W.G.,Teoh Jeremy Y.C.,Compérat Eva,Babjuk Marek,Abufaraj Mohammad,Karakiewicz Pierre I.,Shariat Shahrokh F.,Pradere Benjamin^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference31 articles.

1. European Association of Urology guidelines on non–muscle-invasive bladder cancer (TaT1 and carcinoma in situ)—2019 update;Babjuk;Eur Urol,2019

2. European Association of Urology (EAU) prognostic factor risk groups for non–muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel;Sylvester;Eur Urol,2021

3. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol,2001

4. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines;Witjes;Eur Urol,2021

5. Prognostic factors and risk groups in T1G3 non–muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients;Gontero;Eur Urol,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic and survival outcomes following radical cystectomy for “progressive” and “de novo” muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status;Urologic Oncology: Seminars and Original Investigations;2024-10

2. The role of autophagy dysregulation in low and high-grade nonmuscle invasive bladder cancer: A survival analysis and clinicopathological association;Urologic Oncology: Seminars and Original Investigations;2024-09

3. Comparative analysis of oncological outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer utilizing propensity score matching;2024-06-13

4. Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels;European Urology Oncology;2024-06

5. Identifying the supportive care needs of people affected by non-muscle invasive bladder cancer: An integrative systematic review;Journal of Cancer Survivorship;2024-03-23